MoneyWorks4Me

Albert David informs about outcome of board meeting

09 Aug 2022 Evaluate
In compliance with Regulation 33 of the Listing Regulations, Albert David has informed that it enclosed the following: The Unaudited Financial Results for the quarter ended June 30, 2022 (Results). The Limited Review Report on the aforesaid Results, issued by Basu Chanchani & Deb, Chartered Accountants (FRN: 304049E), Statutory Auditors of the Company. The said Results was recommended by the Audit Committee and approved by the Board of Directors at their respective meetings held today August 09, 2022. The Limited Review Report was also adopted by the Board at the said meeting. All other agenda items were approved in the meeting. The Board Meeting commenced at 9:50 am and concluded at 10:25 am.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..